Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
IKT
Inhibikase Therapeutics Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Inhibikase Therapeutics Inc (IKT) Earnings
Last reported
May 12, 2026
EPS estimate
-$0.11
EPS actual
—
Revenue est.
—
Revenue actual
—
Related:
IKT overview
·
IKT financials
·
IKT news